Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
|
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [1] Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
    Kudlowitz, David
    Muggia, Franco
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (06) : 681 - 685
  • [2] Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?
    Palumbo, Raffaella
    Sottotetti, Federico
    Bernardo, Antonio
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (03) : 209 - 229
  • [3] Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
    Chen, Nianhang
    Brachmann, Carrie
    Liu, Xiping
    Pierce, Daniel W.
    Dey, Joyoti
    Kerwin, William S.
    Li, Yan
    Zhou, Simon
    Hou, Shihe
    Carleton, Michael
    Klinghoffer, Richard A.
    Palmisano, Maria
    Chopra, Rajesh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 699 - 712
  • [4] Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
    Roy, V.
    LaPlant, B. R.
    Gross, G. G.
    Bane, C. L.
    Palmieri, F. M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 449 - 453
  • [5] Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study
    Carrato, Alfredo
    Garcia, Pilar
    Lopez, Rafael
    Macarulla, Teresa
    Rivera, Fernando
    Sastre, Javier
    Gostkorzewicz, Joana
    Benedit, Patricia
    Perez-Alcantara, Ferran
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (04) : 579 - 589
  • [6] Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: A clinical review
    Chirgwin, J.
    Chua, S. L.
    BREAST, 2011, 20 (05) : 394 - 406
  • [7] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Saxena, Ashish
    Schneider, Bryan J.
    Christos, Paul J.
    Audibert, Lauren F.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    MEDICAL ONCOLOGY, 2016, 33 (02) : 1 - 9
  • [8] Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer
    Zhang, Weiwei
    Xu, Yinggang
    Shi, Xiaoqing
    Huang, Xiaofeng
    Chen, Rui
    Xu, Haiping
    Shi, Wenjie
    Wan, Xinyu
    Wang, Ye
    He, Jinzhi
    Li, Cuiying
    Wang, Jue
    Zha, Xiaoming
    NANOMEDICINE, 2022, 17 (10) : 683 - 694
  • [9] Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
    Zhang, Dong-sheng
    Wang, De-shen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Luo, Hui-yan
    Qiu, Miao-zhen
    Wang, Feng
    Li, Yu-hong
    Xu, Rui-hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1065 - 1072
  • [10] Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
    Dong-sheng Zhang
    De-shen Wang
    Zhi-qiang Wang
    Feng-hua Wang
    Hui-yan Luo
    Miao-zhen Qiu
    Feng Wang
    Yu-hong Li
    Rui-hua Xu
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1065 - 1072
12345